Defining the Protein–Protein Interaction Network of the Human Hippo Pathway
2013 · Molecular & Cellular Proteomics · 131 citations
https://doi.org/10.1074/mcp.m113.030049
L
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
264
Papers
8.3K
Citations
50
h-index
165
i10-index
Lin Feng is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Cancer-related molecular mechanisms research & RNA modifications and cancer & MicroRNA in disease regulation. The author has an h-index of 50, co-authored 225 publications.
ORCID: 0000-0001-6461-5838Papers by this author
worksBrain site-specific proteome changes in aging-related dementia
2013 · Experimental & Molecular Medicine · 118 citations
https://doi.org/10.1038/emm.2013.76
PHF6 Regulates Cell Cycle Progression by Suppressing Ribosomal RNA Synthesis
2012 · Journal of Biological Chemistry · 99 citations
https://doi.org/10.1074/jbc.m112.414839
PM2.5-induced ADRB2 hypermethylation contributed to cardiac dysfunction through cardiomyocytes apoptosis via PI3K/Akt pathway
2019 · Environment International · 90 citations
https://doi.org/10.1016/j.envint.2019.03.057
lncRNA LINC00460 Silencing Represses EMT in Colon Cancer through Downregulation of ANXA2 via Upregulating miR-433-3p
2019 · Molecular Therapy — Nucleic Acids · 73 citations
https://doi.org/10.1016/j.omtn.2019.12.006
PARP Inhibition Suppresses Growth of EGFR-Mutant Cancers by Targeting Nuclear PKM2
2016 · Cell Reports · 63 citations
https://doi.org/10.1016/j.celrep.2016.03.070
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat